GCM
ASTH icon

Graham Capital Management’s Astrana Health ASTH Stock Holding History

Graham Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,299
Closed -$319K – 1683
2025
Q1 		$319K Sell
10,299
-13,213
-56% -$440K 0.01% 974
2024
Q4 		$741K Buy
+23,512
New +$1.12M 0.01% 586
2023
Q2 		– Sell
-27,578
Closed -$1.01M – 1352
2023
Q1 		$1.01M Sell
27,578
-40,000
-59% -$1.4M 0.03% 505
2022
Q4 		$2M Buy
67,578
+25,082
+59% +$806K 0.06% 277
2022
Q3 		$1.66M Sell
42,496
-15,224
-26% -$697K 0.07% 294
2022
Q2 		$2.23M Buy
57,720
+5,370
+10% +$204K 0.09% 180
2022
Q1 		$2.54M Buy
52,350
+49,311
+1,623% +$2.54M 0.09% 105
2021
Q4 		$223K Buy
+3,039
New +$250K 0.01% 431

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Graham Capital Management's ASTH Position: Q2 2025 in Review

Graham Capital Management sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 10,299 shares — an estimated $319K sold.

Graham Capital Management first reported a position in ASTH in Q4 2021 and held it in 8 quarters. The position peaked at $2.54M in Q1 2022. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Graham Capital Management reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 10,299 Astrana Health shares in Q2 2025, an estimated $319K.
  • Graham Capital Management first reported a position in Astrana Health in Q4 2021 and held it in 8 quarters.
  • Graham Capital Management's Astrana Health position peaked at $2.54M in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.